Early Assessment of Extracorporeal Shock Wave Myocardial Revascularization (ESMR)

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Research and reviews: journal of medical and health sciences

• Publication date

  2016-06-28

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris.

  2014influential reference
• The Role of Enhanced External Counter Pulsation Therapy in Clinical Practice

  2013cited by this paper
• Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease

  2013influential reference
• Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial.

  2013influential reference
• Extracorporeal shockwave therapy in musculoskeletal disorders

  2012cited by this paper
• Extracorporeal shockwave myocardial revascularization improves clinical symptoms and left ventricular function in patients with refractory angina

  2012influential reference
• A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease

  2012influential reference
• Noninvasive therapy for the management of patients with advanced coronary artery disease

  2012influential reference
• Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future

  2011cited by this paper
• Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure.

  2010influential reference
• Long-term effects of spinal cord stimulation on angina symptoms and quality of life in patients with refractory angina pectoris—results from the European Angina Registry Link Study (EARL)

  2010cited by this paper
• Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris.

  2010influential reference
• Shock wave therapy of ischemic heart disease in the light of general pathology.

  2010cited by this paper
• Cardiac Shock Wave Therapy Reduces Angina and Improves Myocardial Function in Patients With Refractory Coronary Artery Disease

  2010influential reference
• Extracorporeal Cardiac Shock Wave Therapy Ameliorates Clinical Symptoms and Improves Regional Myocardial Blood Flow in a Patient with Severe Coronary Artery Disease and Refractory Angina

  2009influential reference
• Human studies of angiogenic gene therapy.

  2009cited by this paper
• Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits.

  2008cited by this paper
• Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial

  2007cited by this paper
• Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease

  2006influential reference
• Unchain my heart: the scientific foundations of cardiac repair.

  2005cited by this paper
• Extracorporeal Cardiac Shock Wave Therapy Markedly Ameliorates Ischemia-Induced Myocardial Dysfunction in Pigs in Vivo

  2004cited by this paper
• Shock wave therapy induces neovascularization at the tendon–bone junction. A study in rabbits

  2003cited by this paper
• Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards.

  2001cited by this paper

• No citing papers are available for this paper.